Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Buser

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
European Heart Journal|June 12, 2004
Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trialChristoph Kaiser, Gabriela M Kuster, Paul Erne, et al.
JAMA|March 8, 2003
Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trialMatthias Pfisterer, Peter Buser, Stefan Osswald, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|June 21, 2011
Functional assessment of the left atrium by real-time three-dimensional echocardiography using a novel dedicated analysis tool: initial validation studies in comparison with computed tomographyAndreas Rohner, Miriam Brinkert, Nadine Kawel, et al.
Journal of the American College of Cardiology|May 3, 2005
Right atrial pacing impairs cardiac function during resynchronization therapy: acute effects of DDD pacing compared to VDD pacingAlain Bernheim, Peter Ammann, Christian Sticherling, et al.
The American Journal of Cardiology|August 8, 2009
Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitationMihael Potocki, Johannes Mair, Michael Weber, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|November 7, 2009
Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registryAnja Wagner, Oliver Bruder, Steffen Schneider, et al.
JAMA|January 30, 2009
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trialMatthias Pfisterer, Peter Buser, Hans Rickli, et al.
JACC. Cardiovascular Imaging|September 13, 2014
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patientsMatthijs van Kranenburg, Michael Magro, Holger Thiele, et al.
Heart (British Cardiac Society)|January 25, 2013
Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registryDaniel Sürder, Giovanni Pedrazzini, Oliver Gaemperli, et al.
Circulation|November 21, 2014
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trialChristoph Kaiser, Soeren Galatius, Raban Jeger, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
European Heart Journal|June 12, 2004
Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trialChristoph Kaiser, Gabriela M Kuster, Paul Erne, et al.
JAMA|March 8, 2003
Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trialMatthias Pfisterer, Peter Buser, Stefan Osswald, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|June 21, 2011
Functional assessment of the left atrium by real-time three-dimensional echocardiography using a novel dedicated analysis tool: initial validation studies in comparison with computed tomographyAndreas Rohner, Miriam Brinkert, Nadine Kawel, et al.
Journal of the American College of Cardiology|May 3, 2005
Right atrial pacing impairs cardiac function during resynchronization therapy: acute effects of DDD pacing compared to VDD pacingAlain Bernheim, Peter Ammann, Christian Sticherling, et al.
The American Journal of Cardiology|August 8, 2009
Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitationMihael Potocki, Johannes Mair, Michael Weber, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|November 7, 2009
Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registryAnja Wagner, Oliver Bruder, Steffen Schneider, et al.
JAMA|January 30, 2009
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trialMatthias Pfisterer, Peter Buser, Hans Rickli, et al.
JACC. Cardiovascular Imaging|September 13, 2014
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patientsMatthijs van Kranenburg, Michael Magro, Holger Thiele, et al.
Heart (British Cardiac Society)|January 25, 2013
Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registryDaniel Sürder, Giovanni Pedrazzini, Oliver Gaemperli, et al.
Circulation|November 21, 2014
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trialChristoph Kaiser, Soeren Galatius, Raban Jeger, et al.
Pageof 6